Acute Coronary Syndrome
Cough and Cold
Vitamins and Supplements
Interviews | Page 11
How Pharmacists Can Implement Trigger Control Strategies to Help Prevent Allergic Rhinitis
Dennis Williams, PharmD, FAPhA, discusses how pharmacists can help implement trigger control strategies to help prevent allergic rhinitis.
Immunization Recommendations for Special Populations
Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for special populations including pregnant women and health care professionals.
Vaccine Recommendations for Immunocompromised Patients
Jeffrey Goad, PharmD, MPH, FAPhA, discusses vaccine recommendations for immunocompromised patients.
How Signs and Symptoms of Allergic Rhinitis Differ From Those of the Common Cold
Dennis Williams, PharmD, FAPhA, discusses the signs and symptoms of allergic rhinitis and how pharmacists can differentiate them from those of the common cold.
Future Landscape of Antidiabetic Agents for Type 2 Diabetes
Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.
What Must California Pharmacists Discuss with Patients Regarding Birth Control?
Jon Roth, CEO of the California Pharmacists Association, discusses the protocol for pharmacists when they are dispensing birth control.
Successes and Challenges California Pharmacists Have Faced in Dispensing Naloxone
Jon Roth, CEO of the California Pharmacists Association, discusses the successes and challenges California pharmacists have faced in dispensing naloxone.
Counseling Points for Pharmacists to Know About Antidiabetic Agents for Type 2 Diabetics
Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.
Classes of Antidiabetic Agents Recommended as Second-Line Therapies for Type 2 Diabetics
Susan Cornell, PharmD, CDE, FAPhA, FAADE outlines the classes of antidiabetic agents recommended as a second-line treatment for type 2 diabetics.
Promising New Vaccines in the Development Pipeline
Jeffrey Goad, PharmD, MPH, FAPhA, discusses some promising new vaccines that are currently in the development pipeline.
American Journal of Managed Care
Specialty Pharmacy Times
Advertise With Us
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright PharmacyTimes 2006-2016
Pharmacy & Healthcare Communications, LLC.
All Rights Reserved.